PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
31-Aug-2022 Emactuzumab designated as an Orphan Medicinal Product in Europe SynOx Therapeutics Limited
31-Aug-2022 ProtonDx’s Dragonfly Diagnostic System Successfully Deployed at the 2022 Commonwealth Games B3C newswire
31-Aug-2022 Nordic Nanovector ASA Results for the Second Quarter and First Half 2022 Nordic Nanovector
31-Aug-2022 Kinarus Therapeutics Reports H1 2022 Financial Results and Provides Corporate Update Kinarus Therapeutics
31-Aug-2022 New Engagement Grants to Inspire the Next Generation of Scientists Cambridge Crystallographic Data Centre (CCDC)
31-Aug-2022 Immutep granted Japanese patent for Eftilagimod Alpha, a soluble LAG-3 protein, in combination with a PD-1 pathway inhibitor Immutep
31-Aug-2022 Swab and Viral Transport Medium Market is projected to register 6.1% CAGR during forecast period by 2030 MARKITWIRED
31-Aug-2022 Medical Drones Market is anticipated to flourish in the worldwide market at a strong CAGR of 24.3% during the forecast period 2022-2032 MARKITWIRED
31-Aug-2022 Dehydration Monitoring Systems Market is estimated to grow at a CAGR of 7.3% from 2022 to 2032 MARKITWIRED
31-Aug-2022 Radiation Therapy Software Market is predicted to advance at a CAGR of 8.20% from 2022 to 2032 MARKITWIRED
31-Aug-2022 Vascular Testing Devices Market Current and Future Industry Landscape Analysis 2027 MARKITWIRED
31-Aug-2022 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
31-Aug-2022 Laverock Therapeutics founded to develop the next generation of programmable cell therapies Sciad Newswire
31-Aug-2022 Spexis announces presentation of half-year 2022 financial results and participation at upcoming industry and investor events in September Spexis AG
31-Aug-2022 Kinarus Therapeutics Reports H1 2022 Financial Results and Provides Corporate Update Kinarus Therapeutics Holding AG
30-Aug-2022 Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio AcuraBio / Ampersand Capital Partners
30-Aug-2022 Vita 34 records moderate upward trend in the second quarter Vita 34 AG
30-Aug-2022 Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox Integrated DNA Technologies (IDT)
30-Aug-2022 Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure Heidelberg Pharma AG
30-Aug-2022 Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future CluePoints